[HTML][HTML] Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population
…, RL Ursin, JR Shapiro, SE Benner… - The Journal of …, 2020 - Am Soc Clin Investig
Convalescent plasma is a leading treatment for coronavirus disease 2019 (COVID-19), but
there is a paucity of data identifying its therapeutic efficacy. Among 126 potential …
there is a paucity of data identifying its therapeutic efficacy. Among 126 potential …
[HTML][HTML] SARS-CoV-2–specific CD8+ T cell responses in convalescent COVID-19 individuals
…, EW Newell, MP Bettinotti, SE Benner… - The Journal of …, 2021 - Am Soc Clin Investig
Characterization of the T cell response in individuals who recover from severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is critical to understanding its …
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is critical to understanding its …
SARS-CoV-2 antibody avidity responses in COVID-19 patients and convalescent plasma donors
SE Benner, EU Patel, O Laeyendecker… - The Journal of …, 2020 - academic.oup.com
Background Convalescent plasma therapy is a leading treatment for conferring temporary
immunity to COVID-19–susceptible individuals or for use as post-exposure prophylaxis. …
immunity to COVID-19–susceptible individuals or for use as post-exposure prophylaxis. …
Markers of polyfunctional SARS-CoV-2 antibodies in convalescent plasma
…, W Wieland-Alter, RI Connor, PF Wright, SE Benner… - MBio, 2021 - Am Soc Microbiol
Convalescent plasma is a promising therapy for coronavirus disease 2019 (COVID-19), but
the antibody characteristics that contribute to efficacy remain poorly understood. This study …
the antibody characteristics that contribute to efficacy remain poorly understood. This study …
Cytokine and chemokine levels in coronavirus disease 2019 convalescent plasma
…, K Littlefield, R Shrestha, SE Benner… - Open Forum …, 2021 - academic.oup.com
Background The efficacy of coronavirus disease 2019 (COVID-19) convalescent plasma (CCP)
is primarily ascribed as a source of neutralizing anti-severe acute respiratory syndrome …
is primarily ascribed as a source of neutralizing anti-severe acute respiratory syndrome …
[HTML][HTML] Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality
…, MZ Li, TS Bonny, SE Benner… - The Journal of …, 2021 - Am Soc Clin Investig
SARS-CoV-2 (CoV2) antibody therapies, including COVID-19 convalescent plasma (CCP),
monoclonal antibodies, and hyperimmune globulin, are among the leading treatments for …
monoclonal antibodies, and hyperimmune globulin, are among the leading treatments for …
[HTML][HTML] SARS-CoV-2 antibody signatures robustly predict diverse antiviral functions relevant for convalescent plasma therapy
…, W Wieland-Alter, RI Connor, PF Wright, SE Benner… - MedRxiv, 2020 - ncbi.nlm.nih.gov
Convalescent plasma has emerged as a promising COVID-19 treatment. However, the
humoral factors that contribute to efficacy are poorly understood. This study functionally and …
humoral factors that contribute to efficacy are poorly understood. This study functionally and …
[HTML][HTML] CD8+ T cell responses in convalescent COVID-19 individuals target epitopes from the entire SARS-CoV-2 proteome and show kinetics of early differentiation
…, B Abel, EW Newell, MP Bettinotti, SE Benner… - BioRxiv, 2020 - ncbi.nlm.nih.gov
Abstract Characterization of the T cell response in individuals who recover from SARS-CoV-2
infection is critical to understanding its contribution to protective immunity. A multiplexed …
infection is critical to understanding its contribution to protective immunity. A multiplexed …
[HTML][HTML] Higher proinflammatory cytokines are associated with increased antibody titer after a third dose of SARS-CoV-2 vaccine in solid organ transplant recipients
Background. Solid organ transplant recipients (SOTRs) are at increased risk for severe
COVID-19 and exhibit lower antibody responses to SARS-CoV-2 vaccines. This study aimed to …
COVID-19 and exhibit lower antibody responses to SARS-CoV-2 vaccines. This study aimed to …
[HTML][HTML] The effect of induction immunosuppression for kidney transplant on the latent HIV reservoir
The HIV latent viral reservoir (LVR) remains a major challenge in the effort to find a cure for
HIV. There is interest in lymphocyte-depleting agents, used in solid organ and bone marrow …
HIV. There is interest in lymphocyte-depleting agents, used in solid organ and bone marrow …